- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01976221
Priority Setting and Waiting Time Decision in the Referral Process, How and by Whom? (Priority)
Priority Setting and Waiting Time Decision in the Referral Process, How and by Whom? A Prospective Cluster Randomized Controlled Trial on the Effects of an Education Program in Priority Setting and Waiting Time Decision in Referrals
The referral letter is used for different purposes: a request for a special diagnostic assessment or medical treatment that the GP cannot perform for the patient, an invitation to have a second opinion about a clinical problem or a wish for mutual responsibility for the medical handling. The individual referral rate between GPs varies greatly, and is an important determinant of secondary care utilization. We wanted to study the various elements and factors having an impact on the referral process, from the moment the GP decides to refer the patient until the hospital consultant assess the referral and prioritise the patient for further investigation or treatment. How and why are we, the GPs who refer, so different? We wanted to
- identify and describe general practitioners' reflections on and attitudes to the referral process and cooperation with hospital specialists
- identify and describe hospital consultants' reflections on and attitudes to the referral process and cooperation with general practitioners
- identify typologies characterising GPs in the referral practice
Study Overview
Status
Conditions
Detailed Description
Design and Methods:
We did two qualitative and one quantitative study. The first was a focus group study with GPs in CPD groups, the second an individual study with hospital consultants, both analyses by using systematic text condensation. The third was a quantitative registration of impressions, facts and feelings in the referral process using a principal component analysis to find typologies for GPs who refer to hospital.
Participants:
GPs referring to Stavanger University Hospital. Hospital consultants at Stavanger University Hospital.
Intervention: No intervention was performed.
Time schedule:
Data Collection finished May 2014.
Study Type
Contacts and Locations
Study Locations
-
-
-
Stavanger, Norway, 4001
- Stavanger University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
All the 300 GPs referring to Stavanger University Hospital who participate in one of the 58 CPD groups in South Rogaland County and who agree to participate in the study are included.
Exclusion Criteria:
GPs not willing to participate
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Prioritization
Team-based multifaceted interactive training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Use of priority setting and waiting time indication in referrals
Time Frame: 1 year
|
The use of priority setting and waiting time in referrals will be recorded before and after an intervention with group training for general practitioners
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Referral rates
Time Frame: One year
|
The referral rates may be reduced by higher awareness of non-prioritized medical conditions.
The use of priority setting and waiting time according to the national prioritization guidelines can give a higher correlation between GPs and hospital consultants about priority setting and waiting time.
|
One year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inter-rater agreement between GPs and hospital consultants on priority setting and waiting time for patients
Time Frame: One year
|
We will study the inter-rater correlation between GPs and hospital consultants about priority setting and waiting time for patients referred to hospital
|
One year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Anders Baerheim, Professor, Department of Global Public Health and Primary Care, University of Bergen, Norway
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- REK2013/1762
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.